Hermeus
Develops high-Mach unmanned aircraft for national security missions
$350MSeries C
Role not disclosedCP
Canaan Partners
Activity from announced rounds
Activity in this selectionSeries C+
Canaan Partners is an investment firm whose company directory identifies Draig Therapeutics and Solstice Oncology.
Recorded funding activity
Draig develops neuropsychiatric medicines, while Solstice advances an engineered CTLA-4 antibody for cancer treatment. The recorded history also includes Actualyze AI’s enterprise gateway for model access, request security, budgets and routing. Named regional funds retain separate identities.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $350M 1 disclosed · full round size, not this investor’s share